RUIXIAO LU, PH.D.

ALUMIS

Ruixiao Lu, Ph.D. is a recognized leader in the biotech/biopharma industry. She has held functional leadership positions overseeing Biostatistics, Statistical Programming and Clinical Data Management. Currently, she is VP, Head of Biostatistics & Statistical Programming, at Alumis Inc, a precision medicine biotech focusing on autoimmune diseases. Before Alumis, she was VP, Head of Statistics, Clinical Data Management & Data Science overseeing the end-to-end analytical teams, at Quantum Leap Healthcare, the trial sponsor of the I-SPY2 breast cancer trial and I-SPY COVID trial, which are among the first platform trials in clinical research for targeted therapies. Before then, she worked at Genomic Health (acquired by Exact Sciences), with increasing responsibilities leading product development and medical affairs programs, and in the end as the functional head for the statistics and programming. She also contributed to business development due diligence and provided strategic input to product lifecycle management throughout her career.

Ruixiao is dedicated to promoting statistics and data sciences in various non-profit organizations, such as ASA, BBSW and DahShu. At BBSW, she is a co-founder, the President-Elect 2024 and served as the Secretary to the Board (2020- 2023). She was Treasurer and Executive Committee Member of the Board of Directors at ASA (2020-2023), and was elected Vice Chair of District 6, COCGB (2020- 2022) at ASA. She co-founded and co-chairs the Partnership for Clinical Research and Statistics (PCRS) at ASA, which focuses on building partnerships and programs with clinical organizations such as AACR and ASCO. In July 2023, she co-organized and co-chaired the FDA-AACR-ASA workshop on overall survival in oncology drug development which attracted almost 4,000 attendees. She is a co-founder and Board member of DahShu since 2015. 

Ruixiao is elected as a Fellow of ASA in 2024 to recognize her leadership in precision medicine, and vision and commitment to foster the influence and excellence of statistics. Ruixiao received her Ph.D. in Statistics with emphasis on Biostatistics from University of California, Davis, and her bachelor's degree in Statistics from Peking University in Beijing, China.